67 related articles for article (PubMed ID: 18461063)
21. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
22. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial.
Akural EI; Järvimäki V; Länsineva A; Niinimaa A; Alahuhta S
Clin Ther; 2009 Mar; 31(3):560-8. PubMed ID: 19393845
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
[TBL] [Abstract][Full Text] [Related]
25. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
[TBL] [Abstract][Full Text] [Related]
26. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
Wymer JP; Simpson J; Sen D; Bongardt S;
Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
[TBL] [Abstract][Full Text] [Related]
29. Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial.
Richette P; Ravaud P; Conrozier T; Euller-Ziegler L; Mazières B; Maugars Y; Mulleman D; Clerson P; Chevalier X
Arthritis Rheum; 2009 Mar; 60(3):824-30. PubMed ID: 19248105
[TBL] [Abstract][Full Text] [Related]
30. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
31. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
32. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients.
Sebastiani M; Manfredi A; Colaci M; D'amico R; Malagoli V; Giuggioli D; Ferri C
Arthritis Rheum; 2009 May; 61(5):688-94. PubMed ID: 19405007
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
[TBL] [Abstract][Full Text] [Related]
34. Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
Cardozo L; Hessdörfer E; Milani R; Arañó P; Dewilde L; Slack M; Drogendijk T; Wright M; Bolodeoku J;
BJU Int; 2008 Nov; 102(9):1120-7. PubMed ID: 18990175
[TBL] [Abstract][Full Text] [Related]
35. [Treatments of progressive systemic sclerosis].
Vayssairat M; Abdoucheli-Baudot N; Gaitz JP
J Mal Vasc; 2001 Oct; 26(4):258-61. PubMed ID: 11679856
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic management of acral manifestations of systemic sclerosis].
Meyer MF; Daigeler A; Lehnhardt M; Steinau HU; Klein HH
Med Klin (Munich); 2007 Mar; 102(3):209-18. PubMed ID: 17345017
[TBL] [Abstract][Full Text] [Related]
37. Treatment options for the cutaneous manifestations of systemic sclerosis.
Dutz J
Skin Therapy Lett; 2000; 6(1):3-5. PubMed ID: 11027421
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of scleroderma peripheral vascular disease.
Herrick A
Rheum Dis Clin North Am; 2008 Feb; 34(1):89-114; vii. PubMed ID: 18329535
[TBL] [Abstract][Full Text] [Related]
39. Are statins useful for treating vascular involvement in systemic sclerosis?
Blagojevic J; Matucci-Cerinic M
Nat Clin Pract Rheumatol; 2009 Feb; 5(2):70-1. PubMed ID: 19182811
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous revascularization for the treatment of refractory digital ischemia in systemic sclerosis.
Romero-Karam LA; Honan KA; Arain SA; Mayes MD
J Scleroderma Relat Disord; 2023 Feb; 8(1):36-42. PubMed ID: 36743810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
